Arbutus Biopharma Corp (Nasdaq:ABUS)

Health Care/Life Sciences • Pharmaceuticals

CIK 1447028

Company

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Address
701 Veterans Circle
Warminster, Pennsylvania 18974

Employees
None

Stock Info

Close
$2.7000

Day Range
2.6800 - 2.7550

52 Week Range
1.6900 - 3.1450

Average volume
956.56K

Short Interest
3.69M (02/15/24)

% of Float Shorted
2.75%

Market Cap
$491.81M

Revenue
$18.14M

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
$248.51K

P/E Ratio
N/A

EPS
-$0.4387

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer, COO & Director
Michael J McElhaugh MBA

Director
Melissa V Rewolinski PhD

Chairman
Frank M Torti MD, MBA

Independent Director
James R Meyers

Independent Director
Richard C Henriques Jr., MBA

Independent Director
Daniel D Burgess MBA

Independent Director
Keith S Manchester MD

SEC filings

Date	Form	Event
16 Aug, 2024	4
8 Aug, 2024	10-Q
8 Aug, 2024	S-8
5 Aug, 2024	8-K
1 Aug, 2024	8-K
10 Jun, 2024	SC 13G
6 Jun, 2024	8-K
5 Jun, 2024	8-K
28 May, 2024	8-K
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
22 May, 2024	8-K
17 May, 2024	SC 13D/A
9 May, 2024	SC 13D
2 May, 2024	10-Q
2 May, 2024	8-K
2 May, 2024	8-K
10 Apr, 2024	DEF 14A
10 Apr, 2024	DEFA14A
4 Apr, 2024	8-K
5 Mar, 2024	10-K
29 Feb, 2024	8-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
12 Feb, 2024	SC 13G/A
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
8 Jan, 2024	8-K
4 Jan, 2024	8-K	CEO Change
21 Nov, 2023	SC 13G
9 Nov, 2023	8-K
7 Nov, 2023	8-K	CEO Change
7 Nov, 2023	8-K
7 Nov, 2023	10-Q
11 Oct, 2023	8-K
11 Sep, 2023	8-K
11 Sep, 2023	SC 13G
3 Aug, 2023	8-K
3 Aug, 2023	10-Q
3 Aug, 2023	S-8
13 Jul, 2023	3
13 Jul, 2023	4
12 Jul, 2023	4
12 Jul, 2023	3
12 Jul, 2023	3
12 Jul, 2023	8-K
12 Jul, 2023	4
10 Jul, 2023	8-K
21 Jun, 2023	8-K
21 Jun, 2023	8-K
7 Jun, 2023	8-K
30 May, 2023	8-K
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
4 May, 2023	8-K
4 May, 2023	10-Q
27 Apr, 2023	8-K
25 Apr, 2023	8-K
18 Apr, 2023	8-K
12 Apr, 2023	DEFA14A
12 Apr, 2023	DEF 14A
4 Apr, 2023	8-K
16 Mar, 2023	8-K
14 Mar, 2023	8-K
2 Mar, 2023	8-K
2 Mar, 2023	10-K
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	SC 13G
3 Feb, 2023	4
27 Jan, 2023	8-K
5 Jan, 2023	8-K
13 Dec, 2022	8-K
9 Nov, 2022	10-Q
9 Nov, 2022	8-K
4 Nov, 2022	8-K
1 Nov, 2022	8-K
31 Oct, 2022	8-K
24 Oct, 2022	8-K
30 Sep, 2022	8-K
30 Aug, 2022	8-K
4 Aug, 2022	8-K
4 Aug, 2022	10-Q
4 Aug, 2022	S-8
20 Jul, 2022	8-K
27 Jun, 2022	8-K
8 Jun, 2022	8-K
6 Jun, 2022	8-K
31 May, 2022	8-K
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	8-K
26 May, 2022	4
26 May, 2022	4
24 May, 2022	8-K
5 May, 2022	8-K
11 Apr, 2022	DEFA14A
11 Apr, 2022	DEF 14A
3 Mar, 2022	8-K
3 Mar, 2022	8-K
3 Mar, 2022	424B5
3 Mar, 2022	10-K
28 Feb, 2022	8-K
14 Feb, 2022	SC 13G/A
24 Jan, 2022	8-K
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
30 Dec, 2021	D
14 Dec, 2021	8-K
13 Dec, 2021	8-K
10 Dec, 2021	8-K
7 Dec, 2021	8-K
3 Dec, 2021	4
1 Dec, 2021	8-K
18 Nov, 2021	EFFECT
16 Nov, 2021	CORRESP
16 Nov, 2021	UPLOAD
12 Nov, 2021	8-K
12 Nov, 2021	8-K
12 Nov, 2021	4
12 Nov, 2021	3
4 Nov, 2021	10-Q
4 Nov, 2021	8-K
4 Nov, 2021	S-3
20 Oct, 2021	4
20 Oct, 2021	SC 13D/A
8 Oct, 2021	424B5
8 Oct, 2021	8-K
5 Aug, 2021	S-8
5 Aug, 2021	8-K
5 Aug, 2021	10-Q
14 Jul, 2021	8-K
7 Jul, 2021	8-K
6 Jul, 2021	8-K
29 Jun, 2021	8-K
28 Jun, 2021	8-K
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
1 Jun, 2021	8-K
5 May, 2021	8-K
5 May, 2021	10-Q
8 Apr, 2021	DEF 14A
8 Apr, 2021	DEFA14A
1 Apr, 2021	8-K
16 Mar, 2021	8-K
4 Mar, 2021	8-K
4 Mar, 2021	424B5
4 Mar, 2021	8-K
4 Mar, 2021	10-K
26 Feb, 2021	8-K
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G/A
10 Feb, 2021	4
1 Feb, 2021	8-K
25 Jan, 2021	8-K

Last update:2024-03-08 12:06:38.223076

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.